TIPS on Portal Hypertension for Surgeons John R. Potts, III, M.D., F.A.C.S. Program Director in Surgery Assistant Dean Graduate Medical Education University of Texas Medical School - Houston
TIPS on Portal Hypertension
Resuscitation VARICEAL BLEEDING Resuscitation Treat hemorrhagic shock Crystalloid (Limited) Platelets (Rarely) Red Cells + FFP Goal: Tissue Perfusion Monitor: Urine Output Caveat: Do NOT overload
TIPS on Portal Hypertension VARICEAL BLEEDING Initial Treatment Continue Tx hemorrhagic shock IV therapy Sandostatin® INITIATE WHEN Dx SUSPECTED!!!
TIPS on Portal Hypertension VARICEAL BLEEDING Diagnosis 50% UGI bleeds not variceal (MW Tear, Gastritis, Gastric/Duodenal Ulcer) Early endoscopy mandatory Variceal bleeding Dx’d: Active bleeding Stigmata Varices and NO other source
TIPS on Portal Hypertension Initial Therapy VARICEAL BLEEDING Initial Therapy Continue I.V. Sandostatin ® Endoscopic Therapy Sengstaaken-Blakemore tube TIPS Emergency operation
TIPS on Portal Hypertension Supportive Therapy VARICEAL BLEEDING Supportive Therapy Correct coagulopathy FFP, vitamin K, +/- platelets Pulmonary Other infection Encephalopathy Nutrition
TIPS on Portal Hypertension VARICEAL BLEEDING Evaluation Child class History Hepatitis profile Angiography Transplant evaluation
TIPS on Portal Hypertension Child-Pugh Classification Points 123 Bilirubin (mg/dL) < 22 – 3> 3 Albumin (g/dL) > – 3.5< 2.8 Prothrombin time (seconds ↑) 1 – 34 – 6> 6 Ascites NoneSlightModerate Encephalopathy NoneMinimalAdvanced Grade A, 5-6 points; Grade B, 7-9 points; Grade C, points
TIPS on Portal Hypertension VARICEAL BLEEDING Definitive Therapy Rationale: 67% rebleed Most rebleed < 6 weeks Definitive Tx during initial stay
TIPS on Portal Hypertension VARICEAL BLEEDING Definitive Therapy Medical Endoscopic Surgical Radiological
TIPS on Portal Hypertension Medical Therapy VARICEAL BLEEDING Medical Therapy Beta blockade bleeding by cardiac output Goal: 25% in heart rate Reduces # bleeding episodes Does not reduce mortality Use as adjunct
TIPS on Portal Hypertension Endoscopic Banding Occludes venous channels Multiple sessions + surveillance >60% rebleed 1/3 fail treatment complications vs scleroTx = / efficacy vs scleroTx ENDOSCOPIC Tx OF CHOICE
TIPS on Portal Hypertension Endoscopic Banding
TIPS on Portal Hypertension VARICEAL BLEEDING SURGICAL OPTIONS Total Shunt Selective Shunt Partial Shunt Non-Shunt
TIPS on Portal Hypertension Total Shunts End to Side PortocavalSide to Side Portocaval Interposition ShuntsCentral Splenorenal
TIPS on Portal Hypertension Total Shunt Results Prevent rebleed > 90% Thrombosis with graft Encephalopathy rate 40%
TIPS on Portal Hypertension Selective Shunts Goals: Prevent variceal bleeding and encephalopathy Mechanism: Decompress Varices Maintain Portal Perfusion Maintain Portal Hypertension Key: Decompress only gastrosplenic compartment
TIPS on Portal Hypertension Distal Splenorenal Shunt
TIPS on Portal Hypertension DSRS vs Total Shunts Six randomized trials in N.A. Mean follow-up 39 mos (1-8 yrs)
TIPS on Portal Hypertension Partial Shunts Ease of portocaval Limited portal diversion Maintain some liver perfusion Short, straight PTFE graft
TIPS on Portal Hypertension Partial Shunts Sarfeh Ann Surg 200:706,1986
TIPS on Portal Hypertension Partial Shunts Randomized trial in ETOH cirrhotics 20 +/- 11 mos
TIPS on Portal Hypertension Non-Shunt Operations Options Esophageal transection Variceal ligation Devascularize +/- splenectomy Very limited role
TIPS on Portal Hypertension Liver Transplant Indicated for liver failure Not for variceal bleeding Number > 3,500/yr in U.S. 20,000 potential recipients in U.S. 5,000 listed for transplant 24% die on waiting list
TIPS on Portal Hypertension TIPS Transjugular Intrahepatic Portocaval Shunt
TIPS on Portal HypertensionTIPS
TIPS Technically feasible Complications % Infection Intraperitoneal Bleeding Congestive Failure Subcapsular Hematoma Acute Renal Failure Hemobilia Mortality (30 day) % (1) Rossie NEJM 1994;330:165, (2) Rosch Hepatology 1992;16:884, (3) LaBerge Radiology 1993;187:913.
TIPS on Portal Hypertension Problems With TIPS Encephalopathy minimum 15% Occlusion 33 - one year Rebleeding one year (1) 4.7 months (3) (1) Rossie NEJM 1994;330:165, (2) Rosch Hepatology 1992;16:884, (3) LaBerge Radiology 1993;187:913.
TIPS on Portal Hypertension The Role For Tips Refractory bleeding Bridge to transplant Child C (all or only “D Z” ?) ??? refractory ascites Relative contraindication: Poor f/u
Special Cases of Portal Hypertension
TIPS on Portal Hypertension Splenic Vein Thrombosis Etiology: Pancreatitis - Acute or Chronic Pancreatic Carcinoma Hallmark: Isolated Gastric Varices Treatment: Splenectomy (if bleeding)
TIPS on Portal Hypertension Portal Vein Thrombosis Etiology: Congenital - “Cavernous Transformation” Hallmark: Normal Liver Function W/ Varices Treatment: Endo Tx OR DSRS
TIPS on Portal Hypertension Budd-Chiari Syndrome Etiology Hypercoagulable: Estrogens, XRT, Myeloprolif, PNH IVC Occlusion: RA Myxoma, Pericarditis, Membrane Liver Mass High Dose ChemoTx Presentation: Classic Triad Abdominal Pain Ascites Hepatomegaly
TIPS on Portal Hypertension Budd-Chiari Syndrome Diagnosis –U/S, CT, Angio Treatment –NOT a static disease –If NO necrosis Symptomatic Tx –If necrosis Shunt (PCS or MAS) or Transplant
TIPS on Portal Hypertension Some Take Home Points Child A better than Child C Start Sandostatin when Dx suspected β blockade bleeding by C.O Banding safer than scleroTx TIPS: Encephalopathy & occlusion rate
TIPS on Portal Hypertension Some Take Home Points Selective shunt: encephalopathy SV Thrombosis: Presentation & Tx Budd-Chiari: Classic triad Transplant for liver failure
TIPS on Portal Hypertension
Etiology Portal Hypertension Etiology PRE-HEPATIC Portal Vein or Splenic Vein Thrombosis INTRA-HEPATIC Cirrhosis (ETOH, Hepatitis, Other Toxins) POST-HEPATIC Budd-Chiari
TIPS on Portal Hypertension Complications of Portal Hypertension Ascites Encephalopathy Variceal bleeding –Initial management –Evaluation –Definitive therapy –Special cases
TIPS on Portal HypertensionEncephalopathy Etiology: ? Nitrogen compounds Induced by: InfectionDehydration ConstipationBlood in gut No test is diagnostic Therapy : HydrateCleanse gut ↓ proteinFind and treat cause
TIPS on Portal HypertensionAscites Origin: Sinusoidal pressure > colloid oncotic pressure Induced by: Physiologic Stress IV Fluids Complications: Spontaneous Bacterial Peritonitis “Hepatorenal Syndrome”
TIPS on Portal Hypertension Control of Ascites Sodium / Water Restriction Spironolactone Loop Diuretic Large Volume Paracentesis Peritoneal-Venous Shunt (?) TIPS
TIPS on Portal Hypertension VARICEAL BLEEDING General Approach Resuscitation Initial treatment Support Evaluation Definitive therapy
TIPS on Portal HypertensionVasopressin 8-Arginine Vasopressin (ADH) Intense constriction (all beds) + ’s Mesenteric Flow Portal Pressure Stops Bleeding in >80% - ’s Peripheral Ischemia Myocardial Ischemia NTG ’s adverse effects
TIPS on Portal HypertensionSandostatin® Long acting STS analogue +’s Mesenteric Flow Portal Pressure Stops bleeding in > 85% Good as VP but side effects -’s Cost DRUG OF CHOICE
TIPS on Portal Hypertension Portal Vein Anatomy
TIPS on Portal Hypertension Portal Vein Collaterals Five Principle Routes Veins of Retzius Umbilical Vein Hemorrhoids Adhesions Esophageal Varices
TIPS on Portal Hypertension Sclerotherapy VARICEAL BLEEDING Sclerotherapy Intra- or Para- Variceal Occludes venous channels Multiple sessions + surveillance >60% rebleed 1/3 fail treatment 30% complication rate
TIPS on Portal Hypertension Endoscopic Sclerotherapy IntravaricealParavariceal
TIPS on Portal Hypertension Complications of ScleroTx LOCAL Ulceration Stricture Perforation SYSTEMIC Fever Pneumonitis CNS
TIPS on Portal Hypertension Total Shunts Divert most (all?) portal flow Options Portocaval Shunt (E-S or S-S; +/- Graft) Interposition Shunt Central Splenorenal Shunt
TIPS on Portal HypertensionTIPS
Child’s Classification ABC Bilirubin < 22 – 3> 3 Albumin > – 3.5< 2.8 Ascites NoneControlledUn controlled Enceph NoneMinimalAdvanced Nutrition ExcellentGoodPoor
TIPS on Portal Hypertension SclTx vs TIPS Five Randomized Trials patients Mean Follow-up 15 mos (1-36) * p < 0.05 in all but one study ** p < 0.05 in all studies *** n.s. in all but one study where survival w/ SclTx